Viewing Study NCT06232759


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-01-23 @ 3:15 PM
Study NCT ID: NCT06232759
Status: COMPLETED
Last Update Posted: 2024-06-10
First Post: 2024-01-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma
Sponsor: Guangxi Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module